Changbo Wei
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Mesenchymal stem cell research
Papers in
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 3
-
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 5
- Co-authors
- Dongsheng Yu (8 shared papers)Fangfang Jiang (5 shared papers)Binghui Zeng (5 shared papers)Xiliu Zhang (3 shared papers)Ye Li (1 shared paper)Zifeng Liu (1 shared paper)Guanhui Chen (3 shared papers)Ke Zheng (4 shared papers)
In The Last Decade
Changbo Wei
13 papers receiving 412 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 88
- Genetics 40
- Biomedical Engineering 169
- Biomaterials 44
- Periodontics 12
Countries citing papers authored by Changbo Wei
This map shows the geographic impact of Changbo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changbo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changbo Wei more than expected).
Fields of papers citing papers by Changbo Wei
This network shows the impact of papers produced by Changbo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changbo Wei. The network helps show where Changbo Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Changbo Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 75 | |
| 2 | 2019 | 71 | |
| 3 | 2018 | 54 | |
| 4 | 2018 | 49 | |
| 5 | 2018 | 45 | |
| 6 | 2019 | 29 | |
| 7 | 2019 | 28 | |
| 8 | 2016 | 22 | |
| 9 | 2022 | 19 | |
| 10 | 2017 | 12 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 5 | |
| 13 | miR-222 knockdown suppresses epithelial-to-mesenchymal transitionin human oral squamous cell carcinoma. | 2017 | 4 |
About Changbo Wei
Changbo Wei is a scholar working on Molecular Biology, Cancer Research, Biomedical Engineering, Genetics and Materials Chemistry, having authored 13 papers that have together received 418 indexed citations. Recurring topics across this work include Graphene and Nanomaterials Applications (5 papers), MicroRNA in disease regulation (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Mesenchymal stem cell research (4 papers), Circular RNAs in diseases (3 papers), Bone Tissue Engineering Materials (3 papers) and Carbon and Quantum Dots Applications (2 papers). The work is most often cited by research in Cancer Research (88 citations), Genetics (40 citations), Biomedical Engineering (169 citations), Biomaterials (44 citations) and Periodontics (12 citations). Changbo Wei has collaborated with scholars based in China and Germany. Frequent co-authors include Dongsheng Yu, Fangfang Jiang, Binghui Zeng, Xiliu Zhang, Ye Li, Zifeng Liu, Guanhui Chen, Ke Zheng, Jinlong Zhang and Xingmei Feng. Their work appears in journals such as Journal of Biomedical Materials Research Part A, International Journal of Oncology, Cellular Reprogramming, Analytical Cellular Pathology and Cell Proliferation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.